OpenVSafe by OpenVAERS
Search V-safe

GJC-30554-59080

2 vaccinations 5 coded responses 9 check-ins 5 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
802 / CO
Registered
2021-03-03
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-08
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-03
    Registered in v-safe
  3. 2021-03-03
    Dose 2 — Pfizer-BioNTech
  4. 2021-03-03
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-03-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-05
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Itching
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Itching
    Free text: Swollen lymph node
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  9. 2021-03-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  10. 2021-03-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-03-10
    Survey response — day 7, dose 2
    MedDRA: Painful respiration — Feeling: Poor · Site: Itching · Fever · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Stabbing pain when taking deep breaths
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2022-03-03
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous, Anxiety, Hormone level abnormal — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Anxiety Hormonal imbalances Miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-03-03
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  14. 2022-03-04

Vaccinations

DoseDateManufacturerCo-administered
12021-02-08Pfizer-BioNTech
22021-03-03Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-03-03 Unsuccessful

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-04

Systemic reaction (other): Swollen lymph nodes

2021-03-05

Systemic reaction (other): Swollen lymph nodes

2021-03-06

Systemic reaction (other): Swollen lymph node

Release 5 — day 7, dose 2

2021-03-10

Systemic reaction (other): Stabbing pain when taking deep breaths

Release 11 — 12 months, dose 2

2022-03-03

Symptoms: Anxiety Hormonal imbalances Miscarriage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDAnxiety · · ✓
SDHormone level abnormal · · ✓
SROLymphadenopathy ✓ ✓ ✓
SROPainful respiration ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release